We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.49B
AUM Growth
-$310M
Cap. Flow
-$220M
Cap. Flow %
-4%
Top 10 Hldgs %
20.85%
Holding
223
New
43
Increased
76
Reduced
62
Closed
19

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$95.2M
2
WCN
Waste Connections
WCN
+$90.6M
3
TT icon
Trane Technologies
TT
+$86.8M
4
DHI icon
D.R. Horton
DHI
+$68.1M
5
ROL icon
Rollins
ROL
+$57.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.19%
2 Technology 20.42%
3 Industrials 16.23%
4 Consumer Discretionary 7.92%
5 Energy 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBAN icon
76
Huntington Bancshares
HBAN
$34.5B
$26.3M 0.48%
1,615,198
+1,032,634
+177% +$17M
GERN icon
77
Geron
GERN
$860M
$25M 0.46%
7,072,000
MPWR icon
78
Monolithic Power Systems
MPWR
$64.7B
$25M 0.45%
42,207
-51,662
-55% -$37.4M
MDB icon
79
MongoDB
MDB
$26.2B
$24M 0.44%
+102,961
New +$29.1M
UTHR icon
80
United Therapeutics
UTHR
$26.2B
$23.9M 0.44%
67,825
VRSK icon
81
Verisk Analytics
VRSK
$26.1B
$23.7M 0.43%
85,976
+1,224
+1% +$341K
PANW icon
82
Palo Alto Networks
PANW
$265B
$23.3M 0.42%
127,874
-71,362
-36% -$13.5M
INSP icon
83
Inspire Medical Systems
INSP
$1.44B
$23.2M 0.42%
125,090
CDNS icon
84
Cadence Design Systems
CDNS
$91.7B
$22.7M 0.41%
75,483
+59,422
+370% +$17.3M
TGTX icon
85
TG Therapeutics
TGTX
$8.19B
$21.6M 0.39%
718,814
PWR icon
86
Quanta Services
PWR
$98.7B
$21.6M 0.39%
68,208
-57,758
-46% -$18.6M
RPRX icon
87
Royalty Pharma
RPRX
$26.2B
$21M 0.38%
823,390
+50,767
+7% +$1.35M
BHVN icon
88
Biohaven
BHVN
$2.08B
$20.9M 0.38%
560,056
+160,229
+40% +$7.48M
OKE icon
89
Oneok
OKE
$56.1B
$20.1M 0.37%
199,628
+71,589
+56% +$7.32M
IDYA icon
90
IDEAYA Biosciences
IDYA
$3.5B
$19.8M 0.36%
771,844
+436,844
+130% +$12.4M
MSCI icon
91
MSCI
MSCI
$41.9B
$19.3M 0.35%
32,090
+1,089
+4% +$653K
EXLS icon
92
EXL Service
EXLS
$5.21B
$19M 0.35%
428,325
+353,398
+472% +$15.3M
VRT icon
93
Vertiv
VRT
$87.6B
$19M 0.35%
+167,256
New +$19.9M
ANET icon
94
Arista Networks
ANET
$215B
$18.7M 0.34%
+169,538
New +$17.4M
ESI icon
95
Element Solutions
ESI
$8.68B
$18.4M 0.34%
723,989
+21,821
+3% +$590K
KYMR icon
96
Kymera Therapeutics
KYMR
$8.8B
$18.3M 0.33%
455,728
-52,174
-10% -$2.36M
RELY icon
97
Remitly
RELY
$4.94B
$18M 0.33%
+796,604
New +$14.7M
VKTX icon
98
Viking Therapeutics
VKTX
$3.84B
$17.8M 0.32%
442,697
-10,272
-2% -$586K
WEAV icon
99
Weave Communications
WEAV
$522M
$17.7M 0.32%
1,112,540
+993,750
+837% +$14M
VITL icon
100
Vital Farms
VITL
$536M
$17.5M 0.32%
+463,735
New +$16.5M

Similar funds

Eventide Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Eventide Asset Management held 223 positions worth $5.49B, down 5.3% from $5.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eventide Asset Management withdrew a net $220M in Q4 2024, closing 19 positions and reducing 62 holdings. Its most notable exit was Idexx Laboratories, an estimated $95.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in GE Vernova worth $82.1M.

  • Eventide Asset Management's largest Q4 2024 buy was GE Vernova: 249,514 shares worth $82.1M.
  • Eventide Asset Management added most to Workday in Q4 2024, an estimated $50.1M increase.
  • Eventide Asset Management's biggest Q4 2024 reduction was Waste Connections, cutting an estimated $90.6M.
  • Eventide Asset Management fully exited Idexx Laboratories in Q4 2024, selling an estimated $95.2M.
  • Eventide Asset Management's ten largest holdings make up 21% of its $5.49B portfolio in Q4 2024.
  • Eventide Asset Management opened 43 new positions and closed 19 in Q4 2024.
  • Eventide Asset Management's portfolio value fell 5.3% quarter-over-quarter to $5.49B.

Based on Eventide Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.